drugset / Trial / NCT00138762

A Study of Torcetrapib/Atorvastatin vs Atorvastatin Alone or Placebo in Patients With High Cholesterol

NCT00138762

Phase 3 Completed 3800 enrolled Pfizer
RandomizedParallel-groupDouble-blindTreatment

Summary

The Torcetrapib project was terminated on December 2, 2006 due to safety findings. A study to look at lipid levels in subjects taking the study drug, Atorvastatin alone or placebo.

Timeline

Start
2004-07
Primary completion
2006-08
Completion
2006-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule
Subject torcetrapib Small molecule

Indications